| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052537 | The Journal of Urology | 2005 | 5 Pages |
Abstract
Treatment of men with BPH places a significant burden on employees and their employers through direct medical costs as well as through lost work time. Direct and indirect costs to the private sector related to BPH treatment are estimated to be $3.9 billion.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
CHRISTOPHER S. SAIGAL, GEOFFREY JOYCE,